News from NYU Langone Health
NYU Langone Files $11M Plans To Expand And Relocate Pediatric Cardiac Care Hub. (Crain's New York Business)
Paywalled* Crain’s New York Business (7/9) “NYU Langone Health is planning an $11 million expansion of an ambulatory care hub for children with congenital heart disease,” by relocating “its Pediatric Congenital Heart Center at Hassenfeld Children’s Hospital to the first floor of 557 First Ave., according to a recent certificate-of-need application.”
OpenAI’s Sam Altman And Thrive Global’s Arianna Huffington Want To Share The ‘Miracle Drug’ To Extend Human Life. (Fortune)
Fortune (7/8) “Thrive AI Health partnered with Olugbenga G. Ogedegbe, MD, MPH, professor, Department of Population Health, the Dr. Adolph and Margaret Berger Professor of Medicine and Population Health, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, to test and iterate the product on underserved populations more likely to be at risk for chronic conditions.”
Also reporting is TechCrunch (7/8).
Doctors Debunk Social Media Sunscreen Misinformation. (WNBC-TV New York)
WNBC-TV New York (7/8) Dermatologists including Jennifer A. Stein, MD, PhD, professor, the Ronald O. Perelman Department of Dermatology, Perlmutter Cancer Center, associate vice chair, Faculty Practice Group, Department of Dermatology, “say if you don’t wear” sunscreen “now, you’ll regret it later,” with Dr. Stein saying, “Damage can accumulate in your skin, which eventually could cause skin cancer and definitely ages the skin.”
Weight-Loss Drugs May Have Anti-Cancer Benefits. (NBC)
NBC’s Today (7/8) Roshini Raj, MD, clinical associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, discusses the news that GLP-1 agonists may have cancer-reduction benefits, and said, “This story of these weight loss drugs, the GLP-1 agonist, is really interesting because we’re now learning they may have cardiovascular benefits, maybe mental health benefits, and now the latest is anti-cancer benefits.”
NBC (7/8) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, noted that not all cancer risks were shown to be reduced, saying, “The three that were not stomach cancer, breast cancer unfortunately and somewhat surprisingly, and thyroid cancer.”
Thanks To A $1 Billion Gift, Most Johns Hopkins Medical Students Will No Longer Pay Tuition. (AP)
The AP (7/8) “In 2018, Kenneth and Elaine Langone gave $100 million to the NYU Grossman School of Medicine to make tuition free for all current and future medical students through an endowment fund,” and “gave a second gift of $200 million in 2023 to the NYU Grossman Long Island School of Medicine to guarantee free tuition for all medical students.”
Also reporting are the Washington Post (7/8), Fortune (7/8), ABC News (7/8), Newsday (NY) (7/8), the New York Times (7/8), the Philadelphia Inquirer (7/8), MedPage Today (7/8), The Hill (7/8), Philanthropy News Digest (7/8), and a second article in the Philadelphia Inquirer (7/8).
FDA Action Update, June 2024: Approvals, Designation, And Clearance. (Neurology Live)
Neurology Live (7/8) On June 10 “the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted that the data from the phase 3 TRAILBLAZER-ALZ-2 trial...was sufficient enough in demonstrating clinical benefit” of anti-amyloid Therapy Donanemab (Eli Lilly), with Martin Sadowski, MD, PhD, professor, Departments of Neurology, Psychiatry, and Biochemistry and Molecular Pharmacology. He reacted to the news by saying, “The 11:0 vote of the advisory panel represents a solidifying consensus among neurologists that anti-Aß antibodies are a valid disease-modifying strategy for treating patients with AD.”
Transplants Using Animal Organs: Research, Not Lifesaving. (Medscape)
Paywalled* Medscape (7/8)* Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, discusses the potential of genetically engineered animal organs to address organ shortages and emphasizing the importance of organ donation while acknowledging ethical considerations and the experimental nature of such procedures.
5 Foods To Avoid When Taking Ozempic, According To Experts. (Prevention Magazine)
Prevention Magazine (7/8) Priya Jaisinghani, MD, clinical assistant professor, Department of Medicine, the Holman Division of Endocrinology, Diabetes, and Metabolism, recommends prioritizing fruits, vegetables, and lean protein with enough fluid and fiber intake while taking Ozempic, explaining, “The rationale behind this dietary emphasis lies in its contribution to a well-balanced nutritional approach, which necessitates close supervision by healthcare professionals, including physicians and registered dietitians, to address individualized nutritional requirements.”
Revolutionizing Lung Cancer Detection With Self-Taught AI. (Targeted Oncology)
Targeted Oncology (7/8) “Aristotelis Tsirigos, PhD, professor, Department of Medicine, Division of Precision Medicine, and Department of Pathology, and co-director of precision medicine and director of its Applied Bioinformatics Laboratories, discusses a self-taught artificial intelligence (AI) tool being developed to accurately diagnose cases of adenocarcinoma.”
